Top compounds associated with response to ZNF337


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 3e-10
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 1e-09
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 6e-09
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-08
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-08
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 2e-08
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.19 4e-08
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 7e-08
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 2e-07
Download CSV